ANIDO ARMANDO

Director at ADOLOR CORP · on record since May 18, 2006
Director at AUXILIUM PHARMACEUTICALS INC · on record since Jul 18, 2006
CEO & President at AUXILIUM PHARMACEUTICALS INC · on record since Jul 18, 2006
Director at NUPATHE INC. · on record since Jul 27, 2012
Chief Executive Officer at NUPATHE INC. · on record since Jul 27, 2012
Director at Zynerba Pharmaceuticals, Inc. · on record since Aug 10, 2015
Director at NABI BIOPHARMACEUTICALS · on record since Oct 21, 2015
Director at Atea Pharmaceuticals, Inc. · on record since May 13, 2016
Director at SCYNEXIS INC · on record since Jan 23, 2019
Chairman & Chief Exec. Officer at Zynerba Pharmaceuticals, Inc. · on record since May 16, 2017
EVP, Sales & Marketing at MEDIMMUNE INC /DE · on record since Nov 9, 2005

Insider trading activity of ANIDO ARMANDO

Transactions on record: 158; since Mar 10, 2004

Open-market buys: 4; $219.2K

Open-market sells: 17; $4.1M

Companies traded: 8; last filing Jun 30, 2026

Figures computed from official regulatory filings — methodology.

Companies where ANIDO ARMANDO has traded

SCYNEXIS INC18 tx · $31.3K · Jun 30, 2026
Zynerba Pharmaceuticals, Inc.33 tx · $260.6K · Oct 11, 2023
Atea Pharmaceuticals, Inc.2 tx · $39.8K · May 22, 2017
NABI BIOPHARMACEUTICALS1 tx · $68.3K · Oct 21, 2015
NUPATHE INC.7 tx · $8.6M · Feb 25, 2014
ADOLOR CORP27 tx · $290.4K · Dec 8, 2011
AUXILIUM PHARMACEUTICALS INC57 tx · $8.5M · Oct 11, 2011
MEDIMMUNE INC /DE13 tx · $654.3K · Feb 7, 2006

Track record of ANIDO ARMANDO

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of ANIDO ARMANDO

Co-insiders of ANIDO ARMANDO

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
SCYNEXIS INC	Jun 30, 2026	Award	2,875	0.00 USD	—	SEC
SCYNEXIS INC	Jun 30, 2026	AwardD	2,875	0.00 USD	—	SEC
SCYNEXIS INC	Jun 30, 2025	AwardD	23,000	0.00 USD	$0	SEC
SCYNEXIS INC	Jun 30, 2025	Award	23,000	0.00 USD	$0	SEC
SCYNEXIS INC	Jun 21, 2024	AwardD	23,000	0.00 USD	$0	SEC
SCYNEXIS INC	Jun 21, 2024	Award	23,000	0.00 USD	$0	SEC
Zynerba Pharmaceuticals, Inc.	Oct 11, 2023	Other	-26,595	—	—	SEC
Zynerba Pharmaceuticals, Inc.	Oct 11, 2023	Award	240,000	—	—	SEC
Zynerba Pharmaceuticals, Inc.	Oct 11, 2023	OtherD	-190,000	—	—	SEC
Zynerba Pharmaceuticals, Inc.	Oct 11, 2023	Other	-610,000	—	—	SEC
Zynerba Pharmaceuticals, Inc.	Oct 11, 2023	Other	-13,297	—	—	SEC
Zynerba Pharmaceuticals, Inc.	Oct 11, 2023	Other	-566,722	—	—	SEC
Zynerba Pharmaceuticals, Inc.	Sep 14, 2023	Award	64,747	—	—	SEC
Zynerba Pharmaceuticals, Inc.	Sep 14, 2023	Sell	-17,830	1.33 USD	$23.7K	SEC
SCYNEXIS INC	Jun 23, 2023	Award	10,000	0.00 USD	$0	SEC
SCYNEXIS INC	Jun 20, 2023	AwardD	10,000	0.00 USD	$0	SEC
Zynerba Pharmaceuticals, Inc.	Feb 9, 2023	Award	45,406	—	—	SEC
Zynerba Pharmaceuticals, Inc.	Feb 9, 2023	Other	-12,547	0.60 USD	$7.5K	SEC
Zynerba Pharmaceuticals, Inc.	Feb 2, 2023	Other	-11,726	0.60 USD	$7K	SEC
Zynerba Pharmaceuticals, Inc.	Feb 2, 2023	Award	42,437	—	—	SEC
Zynerba Pharmaceuticals, Inc.	Jan 25, 2023	Sell	-35,453	0.60 USD	$21.3K	SEC
Zynerba Pharmaceuticals, Inc.	Jan 25, 2023	Award	250,000	0.00 USD	$0	SEC
Zynerba Pharmaceuticals, Inc.	Jul 20, 2022	Award	43,164	—	—	SEC
Zynerba Pharmaceuticals, Inc.	Jul 20, 2022	Sell	-11,899	1.10 USD	$13.1K	SEC
SCYNEXIS INC	Jun 22, 2022	AwardD	10,000	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
SCYNEXIS INC	Jun 30, 2026	Award	2,875	0.00 USD	—	SEC
SCYNEXIS INC	Jun 30, 2026	AwardD	2,875	0.00 USD	—	SEC
SCYNEXIS INC	Jun 30, 2025	AwardD	23,000	0.00 USD	$0	SEC
SCYNEXIS INC	Jun 30, 2025	Award	23,000	0.00 USD	$0	SEC
SCYNEXIS INC	Jun 21, 2024	AwardD	23,000	0.00 USD	$0	SEC
SCYNEXIS INC	Jun 21, 2024	Award	23,000	0.00 USD	$0	SEC
Zynerba Pharmaceuticals, Inc.	Oct 11, 2023	Other	-26,595	—	—	SEC
Zynerba Pharmaceuticals, Inc.	Oct 11, 2023	Award	240,000	—	—	SEC
Zynerba Pharmaceuticals, Inc.	Oct 11, 2023	OtherD	-190,000	—	—	SEC
Zynerba Pharmaceuticals, Inc.	Oct 11, 2023	Other	-610,000	—	—	SEC
Zynerba Pharmaceuticals, Inc.	Oct 11, 2023	Other	-13,297	—	—	SEC
Zynerba Pharmaceuticals, Inc.	Oct 11, 2023	Other	-566,722	—	—	SEC
Zynerba Pharmaceuticals, Inc.	Sep 14, 2023	Award	64,747	—	—	SEC
Zynerba Pharmaceuticals, Inc.	Sep 14, 2023	Sell	-17,830	1.33 USD	$23.7K	SEC
SCYNEXIS INC	Jun 23, 2023	Award	10,000	0.00 USD	$0	SEC
SCYNEXIS INC	Jun 20, 2023	AwardD	10,000	0.00 USD	$0	SEC
Zynerba Pharmaceuticals, Inc.	Feb 9, 2023	Award	45,406	—	—	SEC
Zynerba Pharmaceuticals, Inc.	Feb 9, 2023	Other	-12,547	0.60 USD	$7.5K	SEC
Zynerba Pharmaceuticals, Inc.	Feb 2, 2023	Other	-11,726	0.60 USD	$7K	SEC
Zynerba Pharmaceuticals, Inc.	Feb 2, 2023	Award	42,437	—	—	SEC
Zynerba Pharmaceuticals, Inc.	Jan 25, 2023	Sell	-35,453	0.60 USD	$21.3K	SEC
Zynerba Pharmaceuticals, Inc.	Jan 25, 2023	Award	250,000	0.00 USD	$0	SEC
Zynerba Pharmaceuticals, Inc.	Jul 20, 2022	Award	43,164	—	—	SEC
Zynerba Pharmaceuticals, Inc.	Jul 20, 2022	Sell	-11,899	1.10 USD	$13.1K	SEC
SCYNEXIS INC	Jun 22, 2022	AwardD	10,000	0.00 USD	$0	SEC